Effect of Hyperoncotic Albumin on Vascular Hemodynamics and Oxygen Delivery Following Orthotopic Liver Transplant
NCT ID: NCT01328132
Last Updated: 2011-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
20 participants
INTERVENTIONAL
2011-03-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Portal Pressure Effects of Phlebotomy Combined to Vasopressin Use in Cirrhotic Patients Undergoing Liver Transplantation
NCT04472312
Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
NCT00511394
Efficacy of High Dose Albumin Therapy in Improving Liver Transplant-free Survival in Patients With Acute Decompensation of Cirrhosis
NCT05956197
The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study
NCT01091233
Intraoperative Hemodynamic Management and Postoperative Outcomes in Liver Transplantation
NCT04732689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Saline
Saline
100 ml of saline will be given in addition to the standard of care every 8 hours for 24 hours.
25% albumin
25% albumin
100 ml of 25% albumin will be given in addition to the standard of care every 8 hours for 24 hours
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Saline
100 ml of saline will be given in addition to the standard of care every 8 hours for 24 hours.
25% albumin
100 ml of 25% albumin will be given in addition to the standard of care every 8 hours for 24 hours
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients from the Critical care Unit
* Patients with a pulmonary artery occlusion catheter Inclusion:patients immediately following liver transplantation
Exclusion Criteria
* Patients who have received \> 300 ml of albumin within 24 hours prior to inclusion
* Patients known to have previous adverse reaction to human albumin solution
* Patients who have religious restriction to receive human blood products
* Patient who have initial graft failure
* Patients with fluctuating hemodynamics
* Concerns of the treating surgeon
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
McGill University Health Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sheldon Magder, MD
Role: PRINCIPAL_INVESTIGATOR
McGill University Health Centre/Research Institute of the McGill University Health Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Victoria Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-287-BMA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.